BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 36993568)

  • 1. First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody.
    Omidvari N; Jones T; Price PM; Ferre AL; Lu J; Abdelhafez YG; Sen F; Cohen SH; Schmiedehausen K; Badawi RD; Shacklett BL; Wilson I; Cherry SR
    medRxiv; 2023 Mar; ():. PubMed ID: 36993568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody.
    Omidvari N; Jones T; Price PM; Ferre AL; Lu J; Abdelhafez YG; Sen F; Cohen SH; Schmiedehausen K; Badawi RD; Shacklett BL; Wilson I; Cherry SR
    Sci Adv; 2023 Oct; 9(41):eadh7968. PubMed ID: 37824612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of
    Farwell MD; Gamache RF; Babazada H; Hellmann MD; Harding JJ; Korn R; Mascioni A; Le W; Wilson I; Gordon MS; Wu AM; Ulaner GA; Wolchok JD; Postow MA; Pandit-Taskar N
    J Nucl Med; 2022 May; 63(5):720-726. PubMed ID: 34413145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-in-Humans Imaging with
    Pandit-Taskar N; Postow MA; Hellmann MD; Harding JJ; Barker CA; O'Donoghue JA; Ziolkowska M; Ruan S; Lyashchenko SK; Tsai F; Farwell M; Mitchell TC; Korn R; Le W; Lewis JS; Weber WA; Behera D; Wilson I; Gordon M; Wu AM; Wolchok JD
    J Nucl Med; 2020 Apr; 61(4):512-519. PubMed ID: 31586002
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Schwenck J; Sonanini D; Seyfried D; Ehrlichmann W; Kienzle G; Reischl G; Krezer P; Wilson I; Korn R; Gonzalez-Menendez I; Quintanilla-Martinez L; Seith F; Forschner A; Eigentler T; Zender L; Röcken M; Pichler BJ; Flatz L; Kneilling M; la Fougere C
    Theranostics; 2023; 13(8):2408-2423. PubMed ID: 37215571
    [No Abstract]   [Full Text] [Related]  

  • 6. Preclinical Evaluation of
    Maresca KP; Chen J; Mathur D; Giddabasappa A; Root A; Narula J; King L; Schaer D; Golas J; Kobylarz K; Rosfjord E; Keliher E; Chen L; Ram S; Pickering EH; Hardwick JS; Rejto PA; Hussein A; Ilovich O; Staton K; Wilson I; McCarthy TJ
    Mol Imaging Biol; 2021 Dec; 23(6):941-951. PubMed ID: 34143379
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    van der Veen EL; Giesen D; Pot-de Jong L; Jorritsma-Smit A; De Vries EGE; Lub-de Hooge MN
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33020241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-PET Monitoring of CD8
    Alsaid H; Cheng SH; Bi M; Xie F; Rambo M; Skedzielewski T; Hoang B; Mohanan S; Comroe D; Gehman A; Hsu CY; Farhangi K; Tran H; Sherina V; Doan M; Groseclose MR; Hopson CB; Brett S; Wilson IA; Nicholls A; Ballas M; Waight JD; Jucker BM
    Mol Imaging Biol; 2023 Jun; 25(3):528-540. PubMed ID: 36266600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative immunoPET of prostate cancer xenografts with 89Zr- and 124I-labeled anti-PSCA A11 minibody.
    Knowles SM; Zettlitz KA; Tavaré R; Rochefort MM; Salazar FB; Stout DB; Yazaki PJ; Reiter RE; Wu AM
    J Nucl Med; 2014 Mar; 55(3):452-9. PubMed ID: 24504052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ImmunoPET imaging of tissue factor expression in pancreatic cancer with
    Hernandez R; England CG; Yang Y; Valdovinos HF; Liu B; Wong HC; Barnhart TE; Cai W
    J Control Release; 2017 Oct; 264():160-168. PubMed ID: 28843831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/CT Imaging of
    Li W; Wang Y; Rubins D; Bennacef I; Holahan M; Haley H; Purcell M; Gantert L; Hseih S; Judo M; Seghezzi W; Zhang S; van der Veen EL; Lub-de Hooge MN; de Vries EGE; Evelhoch JL; Klimas M; Hostetler ED
    Mol Imaging Biol; 2021 Apr; 23(2):250-259. PubMed ID: 33104972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors.
    Hernandez R; Sun H; England CG; Valdovinos HF; Barnhart TE; Yang Y; Cai W
    Mol Pharm; 2016 Jul; 13(7):2563-70. PubMed ID: 27280694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging With PET/CT of Diffuse CD8 T-Cell Infiltration of Skeletal Muscle in Patients With Inclusion Body Myositis.
    Quinn C; Moulton K; Farwell M; Le W; Wilson I; Goel N; McConathy J; Greenberg SA
    Neurology; 2023 Sep; 101(11):e1158-e1166. PubMed ID: 37487752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ImmunoPET Imaging of Murine CD4
    Freise AC; Zettlitz KA; Salazar FB; Lu X; Tavaré R; Wu AM
    Mol Imaging Biol; 2017 Aug; 19(4):599-609. PubMed ID: 27966069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PET-Tracer
    Griessinger CM; Olafsen T; Mascioni A; Jiang ZK; Zamilpa C; Jia F; Torgov M; Romero JM; Marchioni F; Satpayev D; Lee C; Zhang G; Nayak TK; Pincha M; Amann M; Mohan PLB; Richard M; Nicolini VG; Sam J; Claus C; Ferrara C; Brünker P; Bacac M; Umana P; Rüttinger D; Wilson IA; Gudas J; Klein C; Tessier JJL
    Cancer Res; 2020 Jul; 80(13):2903-2913. PubMed ID: 32409308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: dosimetry, biodistribution, and kinetic analyses.
    Gjerløff T; Jakobsen S; Nahimi A; Munk OL; Bender D; Alstrup AK; Vase KH; Hansen SB; Brooks DJ; Borghammer P
    J Nucl Med; 2014 Nov; 55(11):1818-24. PubMed ID: 25324520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I/IIa PET imaging study with
    Joraku A; Hatano K; Kawai K; Kandori S; Kojima T; Fukumitsu N; Isobe T; Mori Y; Sakata M; Hara T; Nasu K; Minami M; Iizumi Y; Nishiyama H
    Ann Nucl Med; 2019 Feb; 33(2):119-127. PubMed ID: 30406361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution and radiation dosimetry of multiple tracers on total-body positron emission tomography/computed tomography.
    Li L; Wan L; Zhao H; Wang C; Wei W; Liu J
    Quant Imaging Med Surg; 2023 Aug; 13(8):5182-5194. PubMed ID: 37581077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate.
    Waaijer SJ; Giesen D; Ishiguro T; Sano Y; Sugaya N; Schröder CP; de Vries EG; Lub-de Hooge MN
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.